How strong is the human evidence for cognition improvements, and how big are the effects?

The short version: the human evidence for lion's mane improving cognition is thin, comes from small short-term trials, and the effect sizes are not well quantified.

The strongest human study in this retrieval is a 2008 double-blind placebo-controlled trial in 50- to 80-year-old Japanese adults with mild cognitive impairment [1]. It reported that the lion's mane group scored significantly better on a cognitive function test at weeks 8, 12, and 16 compared to placebo [1]. But the effect disappeared after stopping the supplement [1]. The trial was small, and the raw data shows the placebo group also improved at weeks 8 and 16 [1], which weakens the claim. No effect size (like Cohen's d or number needed to treat) was reported [1].

A 2020 pilot study cited in a review gave erinacine A-enriched lion's mane mycelia to people with early Alzheimer's and reported better MMSE scores [3]. That study was also small and has not been replicated [3]. The same review notes that robust human evidence is scarce [3].

The remaining records are all lab or animal work. Several show that lion's mane compounds stimulate nerve growth factor (NGF) and BDNF in cell cultures and mice [4][5], and one 2025 in vitro study found a multi-component mix including lion's mane reduced Alzheimer's-related biomarkers in a lab dish [2]. These mechanisms are plausible for cognition, but they are not human evidence.

What is missing: no trial in this retrieval measured cognition in healthy adults, no trial lasted longer than 16 weeks, and no trial reported a standardized effect size. The evidence base is too small and too short to know how big the effect is or who it helps most.

My call: the human evidence for cognition improvement is weak, the effect size is unknown, and the benefit may not persist after stopping. Confidence: low.